324 related articles for article (PubMed ID: 16825950)
21. Oxidative stress damage and oxidative stress responses in the choroid plexus in Alzheimer's disease.
Perez-Gracia E; Blanco R; Carmona M; Carro E; Ferrer I
Acta Neuropathol; 2009 Oct; 118(4):497-504. PubMed ID: 19597827
[TBL] [Abstract][Full Text] [Related]
22. Expression of a truncated tau protein induces oxidative stress in a rodent model of tauopathy.
Cente M; Filipcik P; Pevalova M; Novak M
Eur J Neurosci; 2006 Aug; 24(4):1085-90. PubMed ID: 16930434
[TBL] [Abstract][Full Text] [Related]
23. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
Walton JR
J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
[TBL] [Abstract][Full Text] [Related]
24. Neuroprotective effect of epigallocatechin-3-gallate against beta-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity.
Kim CY; Lee C; Park GH; Jang JH
Arch Pharm Res; 2009 Jun; 32(6):869-81. PubMed ID: 19557365
[TBL] [Abstract][Full Text] [Related]
25. Pharmacogenomics in Alzheimer's disease.
Cacabelos R
Methods Mol Biol; 2008; 448():213-357. PubMed ID: 18370236
[TBL] [Abstract][Full Text] [Related]
26. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice.
Tong XK; Nicolakakis N; Fernandes P; Ongali B; Brouillette J; Quirion R; Hamel E
Neurobiol Dis; 2009 Sep; 35(3):406-14. PubMed ID: 19524673
[TBL] [Abstract][Full Text] [Related]
27. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.
Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S
J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827
[TBL] [Abstract][Full Text] [Related]
28. Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia.
Mahadik SP; Pillai A; Joshi S; Foster A
Int Rev Psychiatry; 2006 Apr; 18(2):119-31. PubMed ID: 16777666
[TBL] [Abstract][Full Text] [Related]
29. Enhanced oxidative stress is an early event during development of Alzheimer-like pathologies in presenilin conditional knock-out mice.
Gu F; Zhu M; Shi J; Hu Y; Zhao Z
Neurosci Lett; 2008 Jul; 440(1):44-8. PubMed ID: 18539391
[TBL] [Abstract][Full Text] [Related]
30. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
31. Oxidative stress induces macroautophagy of amyloid beta-protein and ensuing apoptosis.
Zheng L; Kågedal K; Dehvari N; Benedikz E; Cowburn R; Marcusson J; Terman A
Free Radic Biol Med; 2009 Feb; 46(3):422-9. PubMed ID: 19038331
[TBL] [Abstract][Full Text] [Related]
32. Vitamin E and other antioxidants in neuroprotection.
Behl C
Int J Vitam Nutr Res; 1999 May; 69(3):213-9. PubMed ID: 10389030
[TBL] [Abstract][Full Text] [Related]
33. [The role for oxidative stress in neurodegenerative diseases].
Shibata N; Kobayashi M
Brain Nerve; 2008 Feb; 60(2):157-70. PubMed ID: 18306664
[TBL] [Abstract][Full Text] [Related]
34. Dietary supplementation with apple juice concentrate alleviates the compensatory increase in glutathione synthase transcription and activity that accompanies dietary- and genetically-induced oxidative stress.
Tchantchou F; Graves M; Ortiz D; Rogers E; Shea TB
J Nutr Health Aging; 2004; 8(6):492-6. PubMed ID: 15543422
[TBL] [Abstract][Full Text] [Related]
35. Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems.
Baruch-Suchodolsky R; Fischer B
Biochemistry; 2009 May; 48(20):4354-70. PubMed ID: 19320465
[TBL] [Abstract][Full Text] [Related]
36. Transient intraneuronal A beta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice.
Christensen DZ; Kraus SL; Flohr A; Cotel MC; Wirths O; Bayer TA
Acta Neuropathol; 2008 Dec; 116(6):647-55. PubMed ID: 18974993
[TBL] [Abstract][Full Text] [Related]
37. Estradiol and neurodegenerative oxidative stress.
Nilsen J
Front Neuroendocrinol; 2008 Oct; 29(4):463-75. PubMed ID: 18275991
[TBL] [Abstract][Full Text] [Related]
38. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
[TBL] [Abstract][Full Text] [Related]
39. Oxidative stress: a bridge between Down's syndrome and Alzheimer's disease.
Zana M; Janka Z; Kálmán J
Neurobiol Aging; 2007 May; 28(5):648-76. PubMed ID: 16624449
[TBL] [Abstract][Full Text] [Related]
40. Nuclear factor erythroid 2-related factor 2 protects against beta amyloid.
Kanninen K; Malm TM; Jyrkkänen HK; Goldsteins G; Keksa-Goldsteine V; Tanila H; Yamamoto M; Ylä-Herttuala S; Levonen AL; Koistinaho J
Mol Cell Neurosci; 2008 Nov; 39(3):302-13. PubMed ID: 18706502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
